Biological cost of aminoglycoside resistance Arm/Kam 16S rRNA methyltransferases from natural antibiotic producers and clinical pathogens
Antimicrobial Agents and Chemotherapy · 2025
DOI: 10.1128/aac.00742-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2025. Verfasst von Darija Vidučić und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Faculty of Pharmacy and Biochemistry, University of Zagreb, Zagreb, Croatia. Hauptthemen laut MEDLINE: Methyltransferases, Aminoglycosides, Escherichia coli, Anti-Bacterial Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Commission, International Centre for Genetic Engineering and Biotechnology, Ministry of Science and Technology, Croatia.
Abstract (Originalsprache)
16S rRNA methyltransferases have emerged as critical elements of high-level aminoglycoside resistance in clinical pathogens. We investigated the fitness costs associated with the expression of six methyltransferases isolated from clinical strains (ArmA, RmtA, RmtB, RmtC, RmtD, and NpmA), and two methyltransferases from natural antibiotic producers (Sgm and KamB) in Escherichia coli . Growth competition assays revealed that methyltransferases found in natural producers imposed significantly lower fitness costs than those isolated from clinical strains, allowing resistant populations to persist at stable levels. Translational fidelity assays demonstrated that most methyltransferases induce error-prone phenotypes by allowing increased readthrough of nonsense codons and frameshift mutations, while KamB uniquely increased translational accuracy. Deletion of the housekeeping methyltransferase RsmF further altered these effects, highlighting the complex interplay between endogenous and exogenous methylation processes. Stress response experiments showed varying results: most methyltransferases increased susceptibility to hyperosmotic stress, while several (RmtB, RmtA, ArmA, and KamB) increased tolerance to acidic stress. These findings reveal that 16S rRNA methyltransferases play complex roles in bacterial physiology beyond antibiotic resistance, with important implications for the persistence of resistance and potential therapeutic strategies targeting specific vulnerabilities in resistant bacteria.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, Faculty of Pharmacy and Biochemistry, University of Zagreb, Zagreb, Croatia.
- University Centre Varaždin, University North, Varaždin, Croatia.
- Division of Organic Chemistry and Biochemistry, Ruđer Bošković Institute, Zagreb, Croatia.
ORCID-Profile: Sonja Obranić, Mihaela Matovina, Fedora Babić, Gordana Maravić-Vlahoviček
Förderung
- European Commission
- International Centre for Genetic Engineering and Biotechnology
- Ministry of Science and Technology, Croatia
Zitieren
APA
Vidučić, D., Obranić, S., Matovina, M., Babić, F., & Maravić-Vlahoviček, G. (2025). Biological cost of aminoglycoside resistance Arm/Kam 16S rRNA methyltransferases from natural antibiotic producers and clinical pathogens. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00742-25
Vancouver
Vidučić D, Obranić S, Matovina M, Babić F, Maravić-Vlahoviček G. Biological cost of aminoglycoside resistance Arm/Kam 16S rRNA methyltransferases from natural antibiotic producers and clinical pathogens. Antimicrobial Agents and Chemotherapy. 2025. doi:10.1128/aac.00742-25
BibTeX
@article{Vidui2025,
author = {Vidučić, Darija and Obranić, Sonja and Matovina, Mihaela and Babić, Fedora and Maravić-Vlahoviček, Gordana},
title = {Biological cost of aminoglycoside resistance Arm/Kam 16S rRNA methyltransferases from natural antibiotic producers and clinical pathogens},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2025},
doi = {10.1128/aac.00742-25}
}
EUVIMED